News

SignalRank Celebrates Two Years of Growth and New Model Launch

SignalRank Celebrates Two Years of Growth and New Model Launch

SignalRank Celebrates Two Years of Remarkable Growth

SignalRank, a technology-driven venture investment platform based in Palo Alto, has reached a significant milestone, marking two years of dynamic performance. Over the past two years, SignalRank has demonstrated its commitment to providing valuable insights and tools for investors, culminating in the launch of its new Version 4 (v4) investment selection model.

A Snapshot of SignalRank's Achievements

Since its inception, SignalRank has made impressive strides in the venture investment landscape. Some key highlights of their journey include:

  • Data Collection: SignalRank has amassed two years of performance data, which forms the backbone of its investment strategies.
  • Version 4 Launch: The introduction of v4 showcases a new era in smart investment selection.
  • Accessibility: The SignalRank Index is now available to accredited U.S. investors and comparable entities globally.
  • Investment Milestones: Within just two years, the firm completed 35 Series B investments, establishing itself as a prominent player in this space.

SignalRank's Position in the Market

In an ever-evolving investment environment, SignalRank has positioned itself as the second most active Series B investor globally, only behind Andreessen Horowitz in completed financing transactions. This remarkable feat highlights SignalRank's rigorous exploration of opportunities and partnerships. The company has collaborated with leading investment firms, including Sequoia Capital and General Catalyst, indicating a strong reputation within the industry.

Introducing the SignalRank Index

The innovative SignalRank Index provides qualified investors with a curated portfolio of high-performance AI and technology companies. Among its notable constituents are companies like Mercor, Saronic, Chainguard, and Together AI. The daily pricing of shares enables accredited investors to engage with the Index's dynamic offerings, illustrating the company's intention to broaden access to retail investors and wealth managers in the future.

Early Performance Insights

While investing in ventures often requires patience, preliminary results from the SignalRank Index suggest a promising outlook. Recently reported figures indicate:

  • 2023 Cohort: A 1.26x multiple on invested capital (MOIC).
  • 2024 Cohort: A projected 1.2x MOIC.

These results place the SignalRank Index in the top decile of performance metrics when compared to similar venture investments, reinforcing confidence in the firm's methodologies.

Strengthening Partnerships and Networks

Rob Hodgkinson, Head of Investments at SignalRank, expressed enthusiasm about the growth of the company’s partner network, which has expanded to nearly 300 early-stage firms. He states, "The quality of both deal selection and access continues to improve, helping us deliver a compelling investment product while supporting our partners at a critical stage of company growth." This network plays a crucial role in enhancing the firm’s investment strategies and performance.

Detailed Look at Version 4

The new v4 investment selection model integrates heuristic and machine learning techniques within an advanced ensemble architecture to evaluate high-potential Series B investments. Backtesting of this model reveals impressive results:

  • Rejection Rate: v4 can reject up to 87% of Series B opportunities that are unlikely to perform.
  • Projected Returns: It has the potential to generate an average projected return of 6x over five years for annual investment cohorts.

Keith Teare, CEO and CTO, commented on the model's groundbreaking approach, saying, "This is the first time we’ve blended heuristics with machine learning into a true ensemble model, leading to performance that exceeds any known Series B investor over a five-year horizon." This innovation is poised to significantly benefit both partners and index investors.

About SignalRank

Established in 2021, SignalRank Inc. has quickly become a notable entity in the investment arena. The company is dedicated to developing cutting-edge algorithms designed to identify and support high-potential companies seeking Series B investment. With partnerships among nearly 300 early-stage investors, SignalRank is committed to providing essential follow-on capital to promising companies. Its flagship product, The SignalRank Index, is accessible to qualified investors, ensuring a transparent and publicly quoted share price.

Profiles of Key Investors

SignalRank has garnered support from notable figures in the industry, including:

  • Lip-Bu Tan: CEO of Intel.
  • Tim Draper: from Draper Associates.
  • Blake Grossman: former Vice Chair of BlackRock and iShares CEO.
  • Garry Tan: CEO of Y Combinator.
  • Sanjay Jha: former CEO of GlobalFoundries.
  • Vint Cerf: VP at Google and co-inventor of TCP/IP.
  • Ray Lane: former Oracle President and partner at Kleiner Perkins.

Frequently Asked Questions

What milestones did SignalRank achieve recently?

SignalRank celebrated two years of performance, launched Version 4 of its investment selection model, and completed 35 Series B investments.

What is the SignalRank Index?

The SignalRank Index is a venture capital index offering qualified investors a diversified portfolio of high-growth companies, available to accredited investors.

How has the performance been for the SignalRank Index?

Preliminary results show promising returns, such as a 1.26x multiple on invested capital for the 2023 cohort and a 1.2x for the 2024 cohort.

What is unique about SignalRank’s Version 4 model?

Version 4 combines heuristic and machine learning techniques to enhance investment selections, capable of identifying high-potential Series B investments.

Who are some notable investors in SignalRank?

Notable investors include Lip-Bu Tan, Tim Draper, Blake Grossman, Garry Tan, Sanjay Jha, Vint Cerf, and Ray Lane.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading